MAGKX
Price
$17.59
Change
-$0.25 (-1.40%)
Updated
Jul 13 closing price
Net Assets
478.68M
VSGAX
Price
$122.72
Change
-$1.76 (-1.41%)
Updated
Jul 13 closing price
Net Assets
47.01B
Interact to see
Advertisement

MAGKX vs VSGAX

MAGKX vs VSGAX Comparison Chart in %
View a ticker or compare two or three
VS
MAGKX vs. VSGAX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MAGKX is a Buy and VSGAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSGAX has more cash in the bank: 47B vs. MAGKX (479M). VSGAX pays higher dividends than MAGKX: VSGAX (0.41) vs MAGKX (0.00). MAGKX was incepted earlier than VSGAX: MAGKX (21 years) vs VSGAX (15 years). MAGKX (0.85) is less costly to investors than VSGAX (0.07). MAGKX is a more actively managed with annual turnover of: 32.89 vs. VSGAX (24.00). MAGKX has a lower initial minimum investment than VSGAX: MAGKX (1000) vs VSGAX (3000). MAGKX annual gain was more profitable for investors over the last year : 30.22 vs. VSGAX (26.87). VSGAX return over 5 years is better than : 27.71 vs. MAGKX (-4.52).
MAGKXVSGAXMAGKX / VSGAX
Total Expense Ratio0.850.071,214%
Annual Report Gross Expense Ratio0.850.071,214%
Fund Existence21 years15 years-
Gain YTD20.54117.371118%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets479M47B1%
Annual Yield % from dividends0.000.41-
Returns for 1 year30.2226.87112%
Returns for 3 years41.5951.2681%
Returns for 5 years-4.5227.71-16%
Returns for 10 years32.40181.6018%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
POVYX34.78N/A
N/A
Putnam International Equity Y
CIVVX25.02N/A
N/A
Causeway International Value Inv
LSCNX24.00-0.10
-0.41%
Loomis Sayles Small Cap Value N
BGEKX14.35-0.18
-1.24%
Baillie Gifford International Growth K
TSCGX21.66-0.29
-1.32%
Thrivent Small Cap Growth S